Table 1.
Underlying ICAD criteria | Stent type | GP IIb/IIIa inhibitor | Antithrombotics | Arms | Number | Recanalization (%) | sICH (%) | mRS 0–2 at 3 mo (%) | Death at 3 mo (%) | Comments | |
---|---|---|---|---|---|---|---|---|---|---|---|
Kim et al. (2012–2018/Korea/Retrospective/Single center) [13] | |||||||||||
Tapered shape occlusion | SES (Enterprise) | Used if determined necessary | Post: clopidogrel 300 mg+aspirin 300–500 mg | Direct stenting | 30 | 93 | 0 | 80* | 0 | ICAS criteria somewhat vague | |
Angiographic evidence after 1st microcatheter passage | |||||||||||
Leptomeningeal collateral flow well developed | |||||||||||
Angiographic finding after mechanical thrombectomy | - | Thrombectomy | 73 | 90 | 4 | 47 | 11 | Rescue stenting 41% | |||
Wu et al. (2014–2017/China/Prospective/Nonrandomized/Multicenter) [14] | |||||||||||
Remnant stenosis >70% after mechanical thrombectomy | 25 BAA, 51 BMS (Apollo), or 5 SES (Solitarire) | Used if determined necessary | Pre: clopidogrel 300 mg | Rescue AS | 81 | 91 | 9 | 64 | 11 | Immediate reocclusion 25% at baseline | |
Post: clopidogrel 75 mg+aspirin 100 mg | |||||||||||
- | - | - | No rescue AS | 32 | 74 | 13 | 53 | 16 | Contrast extravasation 22% at baseline | ||
Gross et al. (2004–2018/USA/Retrospective/Single center) [15] | |||||||||||
Angiographic finding after initial attempted thrombectomy | BMS (Minivision, Integrity, Driver, Taxus) | Intraprocedural eptifibatide loading | Post: aspirin+clopidogrel loading after CT/MRI | Rescue stenting | 60 | 93 | 8 | 34 | 34 | ICAS criteria not detailed | |
Feng et al. (China/Retrospective/Single center) [16] | |||||||||||
Angiographic finding after mechanical thrombectomy | SES (15 Solitaire, 27 Enterprise), and BMS (13 Apollo) | Intravenously maintained for 24–36 hours | Post: aspirin 300 mg+clopidogrel 300 mg | Rescue stenting | 55 | 98 | 4 | 79(?) | 21(?) | CTA and FU lost in many patients | |
Yang et al. (2014–2016/China/Retrospective/Multicenter) [17] | |||||||||||
Other major etiologies excluded | 13 BAA, 16 SES, 4 BMS | Intravenously loaded and maintained for at least 24 hours if IV tPA not infused | Post: aspirin 300 mg+clopidogrel 300 mg if IV tPA not infused | Primary AS | 33 | 79 | 9 | 70* | 9 | More favorable baseline characteristics | |
Arterial calcific lesions | |||||||||||
Intracranial atherosclerosis elsewhere | |||||||||||
High risk factors of atherosclerosis | |||||||||||
Additionally, significant fixed focal stenosis after thrombectomy | - | - | - | Thrombectomy | 269 | 86 | 12 | 48 | 20 | Big difference in group size | |
Yoon et al. (2011–2013/Korea/Retrospective/Single center) [18] | |||||||||||
Remnant stenosis >70% after mechanical thrombectomy | 14 BAA, 24 SES (Wingspan) | Not administered | Post: aspirin+clopidogrel | Rescue AS | 38 | 95 | 8 | 63 | 16 | Originally compared with non-ICAS group |
ICAD, intracranial atherosclerotic disease; LVOS, large vessel occlusion stroke; GP, glycoprotein; sICH, symptomatic intracranial hemorrhage; mRS, modified Rankin Scale; SES, self-expanding stent; ICAS, intracranial atherosclerotic stenosis; BAA, balloon angioplasty alone; BMS, balloon-mounted stent; AS, angioplasty and/or stenting; CT, computed tomography; MRI, magnetic resonance imaging; CTA, computed tomographic angiography; FU, follow-up; IV tPA, intravenous tissue plasminogen activator.